Related Experiment Video
Updated: Nov 28, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19
Matteo Briguglio1, Mauro Porta2, Francesca Zuffada3
1IRCCS Orthopedic Institute Galeazzi, Scientific Direction, Milan, Italy.
Coronavirus disease 2019 (COVID-19) causes severe cardiovascular complications, including myocardial injury and thrombosis. Understanding these cardiac effects is crucial for developing effective treatments for COVID-19 patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathophysiology
Background:
- The global impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) continues to strain healthcare systems worldwide.
- COVID-19 presents with unpredictable symptoms, often exacerbated by advanced age, malnutrition, and cardiovascular comorbidities.
- The virus primarily affects the lungs but can lead to fatal cardiovascular consequences in susceptible individuals.
Purpose of the Study:
- To elucidate the pathophysiology of COVID-19 from a cardiological perspective.
- To highlight the major cellular and clinical manifestations of COVID-19 affecting the cardiovascular system.
- To emphasize the importance of a cardiology-focused approach to understanding and managing COVID-19.
Main Methods:
- Review of current literature on SARS-CoV-2 infection and its cardiovascular implications.
- Analysis of cellular mechanisms and clinical presentations of cardiac involvement in COVID-19.
- Emphasis on the cardiological perspective of viral transmission and its effects.
Main Results:
- SARS-CoV-2 can induce myocardial injuries, vasculitis-like syndromes, and atherothrombotic events.
- Electrocardiogram abnormalities may indicate pericardial effusion or cardiac inflammation.
- Microthrombi can lead to ischemic damage, stroke, and autonomic dysfunction.
Conclusions:
- COVID-19 presents significant cardiovascular challenges, including arrhythmias, coronary syndromes, and thrombotic events.
- Tailored cardiological interventions are essential for managing reduced ejection fraction, autonomic dysfunction, and thrombosis.
- Further research and global assessment of therapeutic strategies are needed for effective evidence-based treatments.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

